Skip to main content
Log in

Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

The currently utilized International Neuroblastoma Risk Group (INRG) staging system developed in 2009 uses image-defined risk factors as a measure of surgical risk, separating resectable neuroblastoma from those best preceded by chemotherapy. The previous International Neuroblastoma Staging System was based primarily on surgical findings. We hypothesized there would be a change to the role of the surgeon in neuroblastoma treatment in the more recent decade.

Methods

This is a single center 20-year retrospective analysis of 104 patients with International Classification of Diseases-9 and -10 codes for neuroblastoma. Patient demographics, tumor site, cancer treatment modality, survival, biopsy technique, surgical intervention, and pathology staging were collected. Data was analyzed by analysis of variance (ANOVA) and Student’s t test.

Results

There was a decrease in open surgeries for extra-adrenal neuroblastomas in the later decade (77%, 31%, P = 0.01). There was a narrowing of the time interval to surgery in the later cohort, likely as a result of uniformity in surgical timing on treatment protocols relying on INRG staging.

Conclusions

Our findings mirror changes in practice patterns globally. We found an increase in minimally invasive approaches but did not find a difference in the role of the surgeon under the INRG staging system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics. 2014;134:e945–55.

    Article  Google Scholar 

  2. Parsons SK, Castellino SM, Yabroff KR. Cost, value, and financial hardship in cancer care: implications for pediatric oncology. Am Soc Clin Oncol Educ Book. 2018;38:850–60.

    Article  Google Scholar 

  3. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–31.

    Article  Google Scholar 

  4. Merrihew LE, Fisher PG, Effinger KE. Divergent patterns of incidence in peripheral neuroblastic tumors. J Pediatr Hematol Oncol. 2015;37:502–6.

    Article  CAS  Google Scholar 

  5. Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49–63.

    Article  CAS  Google Scholar 

  6. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17:369–86.

    Article  CAS  Google Scholar 

  7. Sharma R, Mer J, Lion A, Vik TA. Clinical presentation, evaluation, and management of neuroblastoma. Pediatr Rev. 2018;39:194–203.

    Article  Google Scholar 

  8. Tsubota S, Kadomatsu K. Origin and initiation mechanisms of neuroblastoma. Cell Tissue Res. 2018;372:211–21.

    Article  CAS  Google Scholar 

  9. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, et al. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014;32:3169–76.

    Article  Google Scholar 

  10. Sung KW, Yoo KH, Koo HH, Kim JY, Cho EJ, Seo YL, et al. Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features. J Korean Med Sci. 2009;24:461–7.

    Article  Google Scholar 

  11. Davidoff AM. Neuroblastoma. Semin Pediatr Surg. 2012;21:2–14.

    Article  Google Scholar 

  12. Sokol E, Desai AV. The evolution of risk classification for neuroblastoma. Children (Basel). 2019;6:E27.

    Google Scholar 

  13. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27:289–97.

    Article  Google Scholar 

  14. Luksch R, Castellani MR, Collini P, De Bernardi B, Conte M, Gambini C, et al. Neuroblastoma (peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163–81.

    Article  Google Scholar 

  15. Rojas Y, Jaramillo S, Lyons K, Mahmood N, Wu MF, Liu H, et al. The optimal timing of surgical resection in high-risk neuroblastoma. J Pediatr Surg. 2016;51:1665–9.

    Article  Google Scholar 

  16. Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer. 2017. https://doi.org/10.1002/pbc.26605.

    Article  PubMed  Google Scholar 

  17. Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17:520.

    Article  Google Scholar 

  18. Acker SN, Bruny JL, Garrington TP, Partrick DA. Minimally invasive surgical techniques are safe in the diagnosis and treatment of pediatric malignancies. Surg Endosc. 2015;29:1203–8.

    Article  Google Scholar 

  19. Mattioli G, Avanzini S, Pini Prato A, Pio L, Granata C, Garaventa A, et al. Laparoscopic resection of adrenal neuroblastoma without image defined risk factors: a prospective study on 21 consecutive pediatric patients. Pediatr Surg Int. 2014;30:387–94.

    Article  Google Scholar 

  20. Overman RE, Kartal TT, Cunningham AJ, Fialkowski EA, Naik-Mathuria BJ, Vasudeval SA, et al. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatr Blood Cancer. 2020;67:e28153.

    Article  Google Scholar 

  21. Gurria JP, Malek MM, Heaton TE, Gehred A, Lautz TB, Rhee DS, et al. Minimally invasive surgery for abdominal and thoracic neuroblastic tumors: a systematic review by the APSA Cancer committee. J Pediatr Surg. 2020;55:2260–72.

    Article  Google Scholar 

  22. Kawano T, Souzaki R, Sumida W, Shimojima N, Hishiki T, Kinoshita Y, et al. Current thoracoscopic approach for mediastinal neuroblastoma in Japan-results from nationwide multicenter survey. Pediatr Surg Int. 2021;37:1651–8.

    Article  Google Scholar 

  23. Kawano T, Souzaki R, Sumida W, Ishimaru T, Fujishiro J, Hishiki T, et al. Laparoscopic approach for abdominal neuroblastoma in Japan: results from nationwide multicenter survey. Surg Endosc. 2021. https://doi.org/10.1007/s00464-021-08599-4.

    Article  PubMed  Google Scholar 

  24. Ryan AL, Akinkuotu A, Pierro A, Morgenstern DA, Irwin MS. The role of surgery in high-risk neuroblastoma. J Pediatr Hematol Oncol. 2020;42:1–7.

    Article  Google Scholar 

Download references

Funding

No funding was used for this project.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. SB and PA contributed to the material preparation, data collection and analysis, and wrote the first draft of the manuscript. GCN and CR contributed to review and editing as well as supervision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Brianna Spencer.

Ethics declarations

Conflict of interest

No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.

Ethical approval

This study was approved by the Institutional Review Board (IRB#00014901).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spencer, B., Patel, A., Cilley, R. et al. Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience. World J Pediatr 18, 120–125 (2022). https://doi.org/10.1007/s12519-021-00490-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-021-00490-5

Keywords

Navigation